BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 19413639)

  • 21. Expression of VEGF in routinely fixed material using a new monoclonal antibody VG1.
    Turley H; Scott PA; Watts VM; Bicknell R; Harris AL; Gatter KC
    J Pathol; 1998 Nov; 186(3):313-8. PubMed ID: 10211122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours.
    Ohta Y; Shridhar V; Bright RK; Kalemkerian GP; Du W; Carbone M; Watanabe Y; Pass HI
    Br J Cancer; 1999 Sep; 81(1):54-61. PubMed ID: 10487612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer.
    Jubb AM; Turley H; Moeller HC; Steers G; Han C; Li JL; Leek R; Tan EY; Singh B; Mortensen NJ; Noguera-Troise I; Pezzella F; Gatter KC; Thurston G; Fox SB; Harris AL
    Br J Cancer; 2009 Nov; 101(10):1749-57. PubMed ID: 19844231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
    Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N
    Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VEGF-mediated angiogenesis of human pheochromocytomas is associated to malignancy and inhibited by anti-VEGF antibodies in experimental tumors.
    Zielke A; Middeke M; Hoffmann S; Colombo-Benkmann M; Barth P; Hassan I; Wunderlich A; Hofbauer LC; Duh QY
    Surgery; 2002 Dec; 132(6):1056-63; discussion 1063. PubMed ID: 12490855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis.
    Noguera-Troise I; Daly C; Papadopoulos NJ; Coetzee S; Boland P; Gale NW; Lin HC; Yancopoulos GD; Thurston G
    Novartis Found Symp; 2007; 283():106-20; discussion 121-5, 238-41. PubMed ID: 18300417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
    Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
    Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression of vascular endothelial growth factor and microvessel density in ovarian tumor].
    Qi SY
    Ai Zheng; 2003 Mar; 22(3):320-3. PubMed ID: 12654197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-VEGF antibody in experimental hepatoblastoma: suppression of tumor growth and altered angiogenesis.
    McCrudden KW; Hopkins B; Frischer J; Novikov A; Huang J; Kadenhe A; New T; Yokoi A; Yamashiro DJ; Kandel JJ; Middlesworth W
    J Pediatr Surg; 2003 Mar; 38(3):308-14; discussion 308-14. PubMed ID: 12632340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.
    Bruns CJ; Liu W; Davis DW; Shaheen RM; McConkey DJ; Wilson MR; Bucana CD; Hicklin DJ; Ellis LM
    Cancer; 2000 Aug; 89(3):488-99. PubMed ID: 10931447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.
    Vajkoczy P; Farhadi M; Gaumann A; Heidenreich R; Erber R; Wunder A; Tonn JC; Menger MD; Breier G
    J Clin Invest; 2002 Mar; 109(6):777-85. PubMed ID: 11901186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic efficacy of a DNA vaccine targeting the endothelial tip cell antigen delta-like ligand 4 in mammary carcinoma.
    Haller BK; Bråve A; Wallgard E; Roswall P; Sunkari VG; Mattson U; Hallengärd D; Catrina SB; Hellström M; Pietras K
    Oncogene; 2010 Jul; 29(30):4276-86. PubMed ID: 20498640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Periodic Delta-like 4 expression in developing retinal arteries.
    Claxton S; Fruttiger M
    Gene Expr Patterns; 2004 Nov; 5(1):123-7. PubMed ID: 15533827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VEGFR-3 in adult angiogenesis.
    Witmer AN; van Blijswijk BC; Dai J; Hofman P; Partanen TA; Vrensen GF; Schlingemann RO
    J Pathol; 2001 Nov; 195(4):490-7. PubMed ID: 11745682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiopoietin-1 is inversely related to thymidine phosphorylase expression in human breast cancer, indicating a role in vascular remodeling.
    Currie MJ; Gunningham SP; Han C; Scott PA; Robinson BA; Harris AL; Fox SB
    Clin Cancer Res; 2001 Apr; 7(4):918-27. PubMed ID: 11309342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumour angiogenesis.
    Achen MG; Williams RA; Minekus MP; Thornton GE; Stenvers K; Rogers PA; Lederman F; Roufail S; Stacker SA
    J Pathol; 2001 Feb; 193(2):147-54. PubMed ID: 11180159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma.
    Zhang L; Yang N; Conejo-Garcia JR; Katsaros D; Mohamed-Hadley A; Fracchioli S; Schlienger K; Toll A; Levine B; Rubin SC; Coukos G
    Clin Cancer Res; 2003 Jan; 9(1):264-72. PubMed ID: 12538479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelial Delta-like 4 (DLL4) promotes renal cell carcinoma hematogenous metastasis.
    Huang QB; Ma X; Li HZ; Ai Q; Liu SW; Zhang Y; Gao Y; Fan Y; Ni D; Wang BJ; Zhang X
    Oncotarget; 2014 May; 5(10):3066-75. PubMed ID: 24931473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelial Dll4 overexpression reduces vascular response and inhibits tumor growth and metastasization in vivo.
    Trindade A; Djokovic D; Gigante J; Mendonça L; Duarte A
    BMC Cancer; 2017 Mar; 17(1):189. PubMed ID: 28288569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of vascular notch ligand delta-like 4 and inflammatory markers in breast cancer.
    Jubb AM; Soilleux EJ; Turley H; Steers G; Parker A; Low I; Blades J; Li JL; Allen P; Leek R; Noguera-Troise I; Gatter KC; Thurston G; Harris AL
    Am J Pathol; 2010 Apr; 176(4):2019-28. PubMed ID: 20167860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.